These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 19669780

  • 1. Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator.
    Hillenkamp J, Surguch V, Framme C, Gabel VP, Sachs HG.
    Graefes Arch Clin Exp Ophthalmol; 2010 Jan; 248(1):5-11. PubMed ID: 19669780
    [Abstract] [Full Text] [Related]

  • 2. The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF.
    Treumer F, Wienand S, Purtskhvanidze K, Roider J, Hillenkamp J.
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1115-1123. PubMed ID: 28280989
    [Abstract] [Full Text] [Related]

  • 3. Intravitreal Recombinant Tissue Plasminogen Activator and Sulphur Hexafluoride Gas for Submacular Haemorrhage Displacement in Age-Related Macular Degeneration: Looking behind the Blood.
    Maggio E, Peroglio Deiro A, Mete M, Sartore M, Polito A, Prigione G, Guerriero M, Pertile G.
    Ophthalmologica; 2020 Jun; 243(3):224-235. PubMed ID: 31905361
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhage.
    Treumer F, Roider J, Hillenkamp J.
    Br J Ophthalmol; 2012 May; 96(5):708-13. PubMed ID: 22174095
    [Abstract] [Full Text] [Related]

  • 8. Intravitreal injection of recombinant tissue plasminogen activator in submacular hemorrhage: case series.
    Araújo J, Sousa C, Faria PA, Carneiro Â, Rocha-Sousa A, Falcão-Reis F.
    Eur J Ophthalmol; 2016 Apr 12; 26(3):e49-51. PubMed ID: 26428222
    [Abstract] [Full Text] [Related]

  • 9. Subretinal injection of recombinant tissue plasminogen activator for submacular hemorrhage associated with ruptured retinal arterial macroaneurysm.
    Inoue M, Shiraga F, Shirakata Y, Morizane Y, Kimura S, Hirakata A.
    Graefes Arch Clin Exp Ophthalmol; 2015 Oct 12; 253(10):1663-9. PubMed ID: 25418034
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. INTRAVITREAL VERSUS SUBRETINAL ADMINISTRATION OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR COMBINED WITH GAS FOR ACUTE SUBMACULAR HEMORRHAGES DUE TO AGE-RELATED MACULAR DEGENERATION: An Exploratory Prospective Study.
    de Jong JH, van Zeeburg EJ, Cereda MG, van Velthoven ME, Faridpooya K, Vermeer KA, van Meurs JC.
    Retina; 2016 May 12; 36(5):914-25. PubMed ID: 26807631
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degeneration.
    Olivier S, Chow DR, Packo KH, MacCumber MW, Awh CC.
    Ophthalmology; 2004 Jun 12; 111(6):1201-8. PubMed ID: 15177972
    [Abstract] [Full Text] [Related]

  • 14. Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas.
    Hesse L, Schmidt J, Kroll P.
    Graefes Arch Clin Exp Ophthalmol; 1999 Apr 12; 237(4):273-7. PubMed ID: 10208258
    [Abstract] [Full Text] [Related]

  • 15. Pneumatic displacement of submacular hemorrhage with or without tissue plasminogen activator.
    Mizutani T, Yasukawa T, Ito Y, Takase A, Hirano Y, Yoshida M, Ogura Y.
    Graefes Arch Clin Exp Ophthalmol; 2011 Aug 12; 249(8):1153-7. PubMed ID: 21445629
    [Abstract] [Full Text] [Related]

  • 16. [Pars plana vitrectomy, subretinal injection of recombinant tissue plasminogen activator and fluid-gas exchange in the management of massive submacular hemorrhages secondary to age-related macular degeneration].
    Auriol S, Mahieu L, Lequeux L, Quintyn JC, Pagot-Mathis V.
    J Fr Ophtalmol; 2010 Feb 12; 33(2):84-91. PubMed ID: 20092910
    [Abstract] [Full Text] [Related]

  • 17. Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injection for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy.
    Kitagawa Y, Shimada H, Mori R, Tanaka K, Yuzawa M.
    Ophthalmology; 2016 Jun 12; 123(6):1278-86. PubMed ID: 26949121
    [Abstract] [Full Text] [Related]

  • 18. Comparison of subretinal versus intravitreal injection of recombinant tissue plasminogen activator with gas for submacular hemorrhage secondary to wet age-related macular degeneration: treatment outcomes and brief literature review.
    Tranos P, Tsiropoulos GN, Koronis S, Vakalis A, Asteriadis S, Stavrakas P.
    Int Ophthalmol; 2021 Dec 12; 41(12):4037-4046. PubMed ID: 34331185
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of recombinant tissue plasminogen activator and gas versus bevacizumab and gas for subretinal haemorrhage.
    Mayer WJ, Hakim I, Haritoglou C, Gandorfer A, Ulbig M, Kampik A, Wolf A.
    Acta Ophthalmol; 2013 May 12; 91(3):274-8. PubMed ID: 21952010
    [Abstract] [Full Text] [Related]

  • 20. Pneumatic Displacement of Submacular Hemorrhage with Subretinal Air and Tissue Plasminogen Activator: Initial United States Experience.
    Sharma S, Kumar JB, Kim JE, Thordsen J, Dayani P, Ober M, Mahmoud TH.
    Ophthalmol Retina; 2018 Mar 12; 2(3):180-186. PubMed ID: 31047581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.